Causal effects of lipid-lowering therapies on aging-related outcomes and risk of cancers: a drug-target Mendelian randomization study
Aging · 2023
DOI: 10.18632/aging.205347 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2023. Verfasst von Han Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
- Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
- Department of Neurology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Zitieren
APA
Chen, H., Tang, X., Su, W., Li, S., Yang, R., Cheng, H., Zhang, G., & Zhou, X. (2023). Causal effects of lipid-lowering therapies on aging-related outcomes and risk of cancers: a drug-target Mendelian randomization study. Aging. https://doi.org/10.18632/aging.205347
Vancouver
Chen H, Tang X, Su W, Li S, Yang R, Cheng H, et al. Causal effects of lipid-lowering therapies on aging-related outcomes and risk of cancers: a drug-target Mendelian randomization study. Aging. 2023. doi:10.18632/aging.205347
BibTeX
@article{Chen2023,
author = {Chen, Han and Tang, Xinyu and Su, Wei and Li, Shuo and Yang, Ruoyun and Cheng, Hong and Zhang, Guoxin and Zhou, Xiaoying},
title = {Causal effects of lipid-lowering therapies on aging-related outcomes and risk of cancers: a drug-target Mendelian randomization study},
journal = {Aging},
year = {2023},
doi = {10.18632/aging.205347}
}
EUVIMED